Enhanced Theranostic Efficacy of <sup>89</sup>Zr and <sup>177</sup>Lu-Labeled Aflibercept in Renal Cancer: A Viable Option for Clinical Practice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhanced Theranostic Efficacy of ⁸⁹Zr and ¹⁷⁷Lu-Labeled Aflibercept in Renal Cancer: A Viable Option for Clinical Practice

Published:2024-04-08 Issue:5 Volume:21 Page:2544-2554
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Chen Zhao¹^ORCID,Yang Qi¹,Song Lele¹,Qiu Yongkang¹,Wang Tianyao¹,Wu Sitong²,Huang Wenpeng¹,Sun Xinyao¹,Wang Aixiang³⁴,Kang Lei¹^ORCID

Affiliation:

1. Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China

2. Department of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing 100034, China

3. Department of Urology, Peking University First Hospital, Beijing 100034, China

4. Institute of Urology, Peking University, Beijing 100034, China

Funder

Peking University First Hospital

Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park

National Natural Science Foundation of China

Beijing Science Foundation for Distinguished Young Scholars

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.4c00084

Reference35 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update

3. Therapeutic sequencing in advanced renal cell carcinoma: How to choose considering clinical and biological factors

4. Molecular mechanisms and clinical applications of angiogenesis

5. Is the imbalance between pro-angiogenic and anti-angiogenic factors associated with preeclampsia?

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3